L2P RESEARCH Trademark

Trademark Overview


On Friday, January 3, 2020, a trademark application was filed for L2P RESEARCH with the United States Patent and Trademark Office. The USPTO has given the L2P RESEARCH trademark a serial number of 88746144. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 8, 2021. This trademark is owned by Lab TO Pharmacy, LLC. The L2P RESEARCH trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields; Research and development of advanced learning technologies and teaching methods; Research and development of new products; Research and development of new products for others; Research and development of vaccines and medicines; Research and development services in connection with physics; Research and development services in the field of antibodies; Research in the area of semiconductor processing technology; Research in the field of chemistry; Research on the subject of pharmaceuticals; Agrochemical research services; Bacteriological research; Bacteriological consultation and research; Biochemical research; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical research; Conducting clinical trials for others; Consulting services in the field of hydrological research; DNA analysis services for scientific research purposes; DNA screening for scienti...
l2p research

General Information


Serial Number88746144
Word MarkL2P RESEARCH
Filing DateFriday, January 3, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 8, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 12, 2020

Trademark Statements


Disclaimer with Predetermined Text"RESEARCH"
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields; Research and development of advanced learning technologies and teaching methods; Research and development of new products; Research and development of new products for others; Research and development of vaccines and medicines; Research and development services in connection with physics; Research and development services in the field of antibodies; Research in the area of semiconductor processing technology; Research in the field of chemistry; Research on the subject of pharmaceuticals; Agrochemical research services; Bacteriological research; Bacteriological consultation and research; Biochemical research; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical research; Conducting clinical trials for others; Consulting services in the field of hydrological research; DNA analysis services for scientific research purposes; DNA screening for scientific research purposes; Genetic testing for scientific research purposes; Genetic testing of laboratory animals for research purposes; Genotyping services for research or analysis purposes; Industrial research in the field of Biotechnology; Industrial research in the field of Immunology; Integrated scientific research on vermin for greenhouses and harvest crops; Laboratory research services relating to pharmaceuticals; Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of medical imaging; Medical and scientific research in the field of Oncology; Medical and scientific research in the field of Cancer; Medical and scientific research in the field of Nature Therapeutics; Pharmaceutical research and development; Pharmaceutical research services; Product research; Product research and development; Providing information in the field of plant genetics research resources; Providing medical research and scientific research information in the field of oncology via the Internet; Providing scientific research information in the field of Tumor Immunology; Providing scientific research information in the field of Pre clinical Research; Providing scientific research information in the field of Animal Research; Scientific research; Scientific research and development; Scientific research consulting in the field of cosmetics; Scientific research consulting in the field of in vitro fertilization; Scientific research for medical purposes in the area of cancerous diseases; Scientific and technological research relating to patent mapping; Technical research in the field of pharmaceutical studies; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Zoological research and consultation
Pseudo MarkLAB TO PHARMACY RESEARCH

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 8, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLab TO Pharmacy, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAnnville, PA 11703

Party NameLab TO Pharmacy, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAnnville, PA 11703

Trademark Events


Event DateEvent Description
Monday, February 8, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 8, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 7, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 12, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 12, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 22, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 2, 2020ASSIGNED TO LIE
Tuesday, March 24, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 24, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, March 24, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 24, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, March 24, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 24, 2020ASSIGNED TO EXAMINER
Wednesday, January 8, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 7, 2020NEW APPLICATION ENTERED IN TRAM